DECIPHER LABS

Pharmaceuticals & Drugs
₹5.80
-1.53%
Prev close ₹5.89
Get AI-Powered Analysis for DECIPHER LABS Free Analysis → FREE View live price, charts & full analysis for DECIPHER LABS →

DECIPHER LABS Share Price Chart

DECIPHER LABS last traded at ₹5.80 (2026-10-13). Over the past month the stock moved +1.8%, three months the stock moved -20.5%, year the stock moved -44.5%. Its closing range over 52 weeks is ₹5.33 – ₹10.20, with the latest close 43.1% below the high.

Closing prices up to 2026-10-13.

About DECIPHER LABS

Incorporated in 1986, Decipher Labs Ltd deals in pharma and consultancy business.[1]

Business Overview:[1] DCL is in the business of: a) Pharma: Manufacturing and trading of Pharmaceutical products b) Consultancy: It also provides consultancy services

Fundamentals

Market Cap₹6.06 Cr
52W High₹10.99
52W Low₹5
P/E Ratio-15.79
P/B Ratio1
EPS₹-0.38
Dividend Yield0%
ROE (3yr)-7%
Sales Growth (3yr)-32%

Quarterly Results

In the latest quarter (Jun 2026), DECIPHER LABS reported sales of ₹2.41 crore (-17.5%) and net profit of ₹-2.19 crore, compared with the same quarter last year.

DECIPHER LABS quarterly results (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Jun 20262.41-2.16-89.63-2.19-2.17
Mar 20263.600.236.39-0.36-0.36
Dec 20253.21-0.43-13.40-0.54-0.53
Sep 20254.310.122.780.020.02
Jun 20252.92-3.32-113.70-3.43-3.40
Mar 20253.50-6.58-188.00-4.11-4.07
Dec 20245.80-0.63-10.86-0.59-0.58
Sep 20245.87-1.33-22.66-1.33-1.32
Year-on-year change vs the same quarter last year
Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales growth-21.6%-30.0%-66.9%-60.8%-26.6%-44.7%+2.9%-17.5%
Operating profit growth–-584.6%-643.8%-353.4%––––
Net profit growth–-6000.0%-442.5%-461.1%––––
EPS growth–-5900.0%-442.0%-461.7%––––
OPM %-22.7%-10.9%-188.0%-113.7%2.8%-13.4%6.4%-89.6%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Annual Financials

In the latest year (Mar 2026), DECIPHER LABS reported sales of ₹14.05 crore (-37.9%) and net profit of ₹-3.08 crore, compared with the previous year.

DECIPHER LABS annual profit & loss (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Mar 202614.05-3.39-24.13-3.08-3.05
Mar 202522.61-7.23-31.98-5.08-5.03
Mar 202435.88-0.68-1.90-1.68-1.66
Mar 202345.57-4.17-9.15-2.68-2.65
Mar 202265.326.039.2311.3811.27
Mar 202155.563.486.261.401.39
Mar 202023.992.5210.501.101.09
Mar 20198.060.455.580.410.51
Year-on-year change vs the previous year
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales growth+690.2%+197.6%+131.6%+17.6%-30.2%-21.3%-37.0%-37.9%
Operating profit growth+542.9%+460.0%+38.1%+73.3%-169.2%–––
Net profit growth+127.8%+168.3%+27.3%+712.9%-123.6%–––
EPS growth+131.8%+113.7%+27.5%+710.8%-123.5%–––
OPM %5.6%10.5%6.3%9.2%-9.2%-1.9%-32.0%-24.1%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Shareholding

Promoter Holding16.43%

AI Analysis

No AI analysis generated yet for DECIPHER LABS.

Get Free AI Stock Analysis FREE →

Latest News

Frequently Asked Questions

What is the share price of DECIPHER LABS today?

DECIPHER LABS shares were last quoted at ₹5.80 (-1.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.

What is the P/E ratio of DECIPHER LABS?

DECIPHER LABS has a price-to-earnings (P/E) ratio of -15.79 and a price-to-book (P/B) ratio of 1.00. The industry P/E is 52.82.

What is the 52-week high and low of DECIPHER LABS?

The 52-week high of DECIPHER LABS is ₹10.99 and the 52-week low is ₹5.00.

What is the market cap of DECIPHER LABS?

The market capitalisation of DECIPHER LABS is about ₹6.06 crore.

How did DECIPHER LABS perform in its latest quarterly results?

In the latest quarter (Jun 2026), DECIPHER LABS reported sales of ₹2.41 crore (-17.5%) and net profit of ₹-2.19 crore, compared with the same quarter last year.

Is DECIPHER LABS a good stock to buy?

This page is for information and is not investment advice. As per the data shown here, DECIPHER LABS has a 3-year ROE of -7.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.

What is the promoter holding in DECIPHER LABS?

Promoters hold about 16.43% of DECIPHER LABS.

Which sector does DECIPHER LABS belong to?

DECIPHER LABS belongs to the Pharmaceuticals & Drugs sector.

Other Pharmaceuticals & Drugs stocks

All Pharmaceuticals & Drugs stocks · Browse all stocks A–Z

Go to live page for DECIPHER LABS →